SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Clinical trials for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outperform keytruda in head and neck cancer
Disease control Recruiting nowThis Phase 3 trial is testing two new drug combinations—ivonescimab alone or with ligufalimab—against the standard treatment pembrolizumab (Keytruda) for people with advanced head and neck cancer that has come back or spread. The study will enroll about 780 participants to see if…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE3 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a 3-Week radiation course replace 6 weeks for head and neck cancer?
Disease control Recruiting nowThis study compares a standard 6-week radiation course after surgery to a shorter 3-week course for people with head and neck cancer. The goal is to see if the shorter schedule works just as well at preventing cancer from coming back. About 369 participants will be randomly assig…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE2, PHASE3 • Sponsor: All India Institute of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Recruiting nowThis early-stage trial tests a fluorescent dye attached to the cancer drug nivolumab. The dye is meant to make cancer cells glow during surgery, helping surgeons remove them more precisely. The study will enroll 40 people with head and neck cancer who are already scheduled for su…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jul 02, 2026 00:00 UTC
-
Glow-in-the-dark dye could help surgeons spot hidden cancer during head and neck surgery
Diagnosis Recruiting nowThis study tests whether a dye called ICG can help surgeons see tumor tissue more clearly during head and neck cancer surgery. About 30 adults with squamous cell carcinoma who are at risk of recurrence will receive the dye before surgery, and doctors will use a special camera to …
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Blood test may spot head and neck Cancer's return
Knowledge-focused Recruiting nowThis study looks at whether a blood test that finds tumor DNA can predict if head and neck cancer comes back after treatment. About 250 adults who have finished curative treatment will give blood samples over time. The goal is to see if a positive test result matches cancer relap…
Matched conditions: SQUAMOUS CELL CARCINOMA HEAD AND NECK CANCER (HNSCC)
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC